tiprankstipranks
Trending News
More News >
Aurora Cannabis (US) (TSE:ACB)
:ACB
Canadian Market
Advertisement

Aurora Cannabis (ACB) Earnings Dates, Call Summary & Reports

Compare
1,450 Followers

Earnings Data

Report Date
Feb 05, 2026
TBA (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
0.16
Last Year’s EPS
0.57
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call revealed strong financial performance with record revenue growth, improved margins, and significant increases in adjusted EBITDA. Aurora’s strategic focus on international markets and GMP-certified facilities positions it well for future growth. However, challenges persist, particularly in the consumer cannabis segment and potential regulatory changes in Germany and Australia. Cash flow concerns also remain.
Company Guidance
During the fiscal second quarter of 2026, Aurora Cannabis reported impressive financial performance, with net revenue rising by 11% to $90 million compared to the previous year. This growth was driven by a 15% increase in global medical cannabis revenue and a 22% rise in international revenue. The company's consolidated adjusted gross margin improved by 700 basis points to 61%, significantly exceeding their initial target of 60% for medical cannabis, reaching 69% this quarter. Additionally, adjusted EBITDA surged by more than 52% to $15 million. Aurora's strong cash position was highlighted, with $142 million in cash and no cannabis-related debt. The company remains the largest medical cannabis provider in Canada and leads in major international markets such as Germany, Australia, Poland, and the U.K. Aurora continues to focus on operational efficiencies, regulatory expertise, and strategic investments in GMP-certified facilities to sustain its competitive advantage and profitability in the global medical cannabis market.
Record Net Revenue Growth
Net revenue rose 11% to $90 million in Q2 2026 compared to Q2 2025, with global medical cannabis revenue increasing 15% and international revenue increasing 22%.
Improved Adjusted Gross Margin
Consolidated adjusted gross margin improved 700 basis points to 61%, with the medical cannabis business consistently exceeding a 60% adjusted gross margin target, reaching 69% in Q2 2026.
Significant Increase in Adjusted EBITDA
Adjusted EBITDA rose more than 52% to $15 million, illustrating a strong focus on profitable and sustainable growth.
Strong International Market Position
Aurora is a market leader in Germany, Australia, Poland, and the U.K., and has a strong foothold in emerging markets with GMP-certified facilities in Canada and Germany.

Aurora Cannabis (TSE:ACB) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:ACB Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 05, 2026
2026 (Q3)
0.16 / -
0.57
Nov 05, 2025
2026 (Q2)
0.02 / -0.91
-0.22-313.64% (-0.69)
Aug 06, 2025
2026 (Q1)
0.16 / -0.26
0.08-425.00% (-0.34)
Jun 18, 2025
2025 (Q4)
0.13 / -0.35
-0.412.50% (+0.05)
Feb 05, 2025
2025 (Q3)
<0.01 / 0.57
-0.5214.00% (+1.07)
Nov 06, 2024
2025 (Q2)
-0.11 / -0.22
0
Aug 07, 2024
2025 (Q1)
-0.17 / 0.08
-0.8110.00% (+0.88)
Jun 20, 2024
2024 (Q4)
-0.18 / -0.40
13.626-102.94% (-14.03)
Feb 08, 2024
2024 (Q3)
-0.13 / -0.50
-2.580.00% (+2.00)
Nov 09, 2023
2024 (Q2)
- / 0.00
-2
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:ACB Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
C$6.42C$6.29-2.02%
Aug 06, 2025
C$6.34C$5.81-8.36%
Jun 18, 2025
C$8.02C$6.40-20.20%
Feb 05, 2025
C$5.28C$7.65+44.89%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Aurora Cannabis (US) (TSE:ACB) report earnings?
Aurora Cannabis (US) (TSE:ACB) is schdueled to report earning on Feb 05, 2026, TBA (Confirmed).
    What is Aurora Cannabis (US) (TSE:ACB) earnings time?
    Aurora Cannabis (US) (TSE:ACB) earnings time is at Feb 05, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:ACB EPS forecast?
          TSE:ACB EPS forecast for the fiscal quarter 2026 (Q3) is 0.16.

            Aurora Cannabis (TSE:ACB) Earnings News

            Aurora Cannabis (TSE:ACB) Plunges after Earnings
            Premium
            Market News
            Aurora Cannabis (TSE:ACB) Plunges after Earnings
            1y ago
            Aurora Cannabis (NASDAQ:ACB) Slides on Weak Q4
            Premium
            Market News
            Aurora Cannabis (NASDAQ:ACB) Slides on Weak Q4
            3y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis